Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

  • Maxine Sun
  • Firas Abdollah
  • Lars Budäus
  • Daniel Liberman
  • Zhe Tian
  • Monica Morgan
  • Rupinder Johal
  • Jan Schmitges
  • Shahrokh F Shariat
  • Francesco Montorsi
  • Markus Graefen
  • Paul Perrotte
  • Pierre I Karakiewicz

Related Research units

Abstract

Retroperitoneal lymphadenectomy (RPLND), chemotherapy, and active surveillance represent treatment options for patients with nonseminomatous germ-cell tumors of the testis (NSGCTT). Our objective was to assess the utilization rate of RPLND in patients with NSGCTT.

Bibliographical data

Original languageEnglish
Article number10
ISSN1068-9265
Publication statusPublished - 2011
pubmed 21509630